Figure 4.
Figure 4. CIR and DFS according to oncogenetics combined with MRD. (A) CIR in patients with MRD ≥10−4, comparing gHiR and gLoR patients. (B) DFS in patients with MRD ≥10−4, comparing gHiR and gLoR patients. (C) CIR in patients with MRD <10−4, comparing gHiR and gLoR patients. (D) DFS in patients with MRD <10−4, comparing gHiR and gLoR patients.

CIR and DFS according to oncogenetics combined with MRD. (A) CIR in patients with MRD ≥10−4, comparing gHiR and gLoR patients. (B) DFS in patients with MRD ≥10−4, comparing gHiR and gLoR patients. (C) CIR in patients with MRD <10−4, comparing gHiR and gLoR patients. (D) DFS in patients with MRD <10−4, comparing gHiR and gLoR patients.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal